Quick Answer
EXAGEN INC. reported Stockholders Equity of $17.45 million for the year ending 2025.
- EXAGEN INC. showed an increase of +82.9% in Stockholders Equity from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$98.88 million | Q2 2018: -$103.29 million | Q3 2018: -$107.81 million | Q1 2019: -$116.77 million | Q2 2019: -$121.73 million | Q3 2019: $58.65 million | Q1 2020: $50.54 million | Q2 2020: $47.84 million | Q3 2020: $44.47 million | Q1 2021: $101.47 million | Q2 2021: $96.38 million | Q3 2021: $90.80 million | Q1 2022: $76.16 million | Q2 2022: $62.82 million | Q3 2022: $56.19 million | Q1 2023: $35.94 million | Q2 2023: $31.90 million | Q3 2023: $27.50 million | Q1 2024: $19.99 million | Q2 2024: $17.59 million | Q3 2024: $12.87 million | Q1 2025: $6.40 million | Q2 2025: $21.03 million | Q3 2025: $18.14 million.
- Over the full 9 years of available data (2017 to 2025), EXAGEN INC.'s Stockholders Equity has grown by 118.0%.
- Historical annual values: Fiscal year 2025: $17.45 million | Fiscal year 2024: $9.54 million | Fiscal year 2023: $22.69 million | Fiscal year 2022: $42.46 million | Fiscal year 2021: $84.94 million | Fiscal year 2020: $41.84 million | Fiscal year 2019: $55.66 million | Fiscal year 2018: -$111.97 million | Fiscal year 2017: -$96.68 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: